81 related articles for article (PubMed ID: 6383334)
21. [Distribution of lectin-receptors in ovarian cystadenoma and cystadenocarcinoma].
Hu NP
Zhonghua Bing Li Xue Za Zhi; 1989 Mar; 18(1):40-2. PubMed ID: 2776253
[TBL] [Abstract][Full Text] [Related]
22. [Clinical course of benign epithelial ovarian tumors].
Mitrokhina MV
Vopr Onkol; 1980; 26(3):78-81. PubMed ID: 7368661
[TBL] [Abstract][Full Text] [Related]
23. Benign ovarian serous tumors: a re-evaluation and proposed reclassification of serous "cystadenomas" and "cystadenofibromas".
Seidman JD; Mehrotra A
Gynecol Oncol; 2005 Feb; 96(2):395-401. PubMed ID: 15661227
[TBL] [Abstract][Full Text] [Related]
24. [Serous and mucinous ovarian cystadenomas at the limit of malignancy].
Chenevart P; Gloor E
Schweiz Med Wochenschr; 1980 Apr; 110(14):531-9. PubMed ID: 7375903
[TBL] [Abstract][Full Text] [Related]
25. 17 beta-hydroxysteroid dehydrogenase in common epithelial ovarian tumors.
Sasano H; Suzuki T; Niikura H; Kaga K; Sato S; Yajima A; Rainey WE; Nagura H
Mod Pathol; 1996 Apr; 9(4):386-91. PubMed ID: 8729977
[TBL] [Abstract][Full Text] [Related]
26. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
27. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
Brun JL; Cortez A; Commo F; Uzan S; Rouzier R; Daraï E
Int J Oncol; 2008 Dec; 33(6):1239-46. PubMed ID: 19020757
[TBL] [Abstract][Full Text] [Related]
28. [Mural nodules of anaplastic carcinoma in bilateral ovarian borderline mucinous cystadenoma: a case report].
Guilbeau C; Soubeyrand MS; Devillebichot C; Sage M; Collin F; Arnould L
Ann Pathol; 2003 Sep; 23(4):340-4. PubMed ID: 14597898
[TBL] [Abstract][Full Text] [Related]
29. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
30. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of HLA-DR antigen in serous ovarian tumors.
Tamiolakis D; Kotini A; Venizelos J; Jivannakis T; Simopoulos C; Papadopoulos N
Clin Exp Med; 2003 Sep; 3(2):113-8. PubMed ID: 14598186
[TBL] [Abstract][Full Text] [Related]
32. A huge ovarian mucinous cystadenoma in a 14-year-old premenarchal girl: review on ovarian mucinous tumor in premenarchal girls.
Karaman A; Azili MN; Boduroğlu EC; Karaman I; Erdoğan D; Cavuşoğlu YH; Aslan MK; Cakmak O
J Pediatr Adolesc Gynecol; 2008 Feb; 21(1):41-4. PubMed ID: 18312801
[TBL] [Abstract][Full Text] [Related]
33. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Furuya M; Ishikura H; Kawarada Y; Ogawa Y; Sakuragi N; Fujimoto S; Yoshiki T
Gynecol Oncol; 2000 Aug; 78(2):106-12. PubMed ID: 10926788
[TBL] [Abstract][Full Text] [Related]
34. Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors.
Sugai M; Umezu H; Yamamoto T; Jiang S; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2008 Nov; 58(11):681-6. PubMed ID: 18844932
[TBL] [Abstract][Full Text] [Related]
35. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
[TBL] [Abstract][Full Text] [Related]
36. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
McCluggage WG; Young RH
Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
[TBL] [Abstract][Full Text] [Related]
37. Interphase cytogenetic analysis of mucinous ovarian neoplasms.
Diebold J; Siegert S; Baretton GB; Suchy B; Meier W; Haas CJ; Löhrs U
Lab Invest; 1997 May; 76(5):661-70. PubMed ID: 9166285
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of pregnancy-specific protein (SP1) and placenta-specific tissue proteins (PP5, PP10, PP11 and PP12) in ovarian adenocarcinomas.
Inaba N; Ishige H; Ijichi M; Satoh N; Ohkawa R; Sekiya S; Shirotake S; Takamizawa H; Renk T; Bohn H
Oncodev Biol Med; 1982; 3(5-6):379-89. PubMed ID: 6755403
[TBL] [Abstract][Full Text] [Related]
39. Human ovarian tumors express gamma-glutamyl transpeptidase.
Hanigan MH; Frierson HF; Brown JE; Lovell MA; Taylor PT
Cancer Res; 1994 Jan; 54(1):286-90. PubMed ID: 7903206
[TBL] [Abstract][Full Text] [Related]
40. Pathology associated with ovarian cystadenomas and cystadenocarcinomas.
Nieminen U; Purola E
Ann Chir Gynaecol Fenn; 1969; 58(3):255-9. PubMed ID: 5380309
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
